Supplementary Files

<strong>Table S1: </strong>Datasets used in this study. <strong>Table S2: </strong>Primer sequences used in this study. <strong>Table S3: </strong>125 exosome-related genes from literature and databases. <strong>Table S4: </strong>4355 OS-related lncRNAs by univariate cox regression analysis. <strong>Table S5: </strong>Genes of 15 exosome-related modules defined by a correlation coefficient over 0.3 in module-trait correlation analysis. <strong>Table S6:</strong> 42 hub genes of exosome-related modules defined by gene significance over 0.3 and module membership over 0.8. <strong>Table S7: </strong>Restricted mean survival time between risk groups at different time points. <strong>Table S8:</strong> Correlation between 26 modeling lncRNAs and 812 FDA approved drug targets. A correlation coefficient over 0.3 is considered exosome-related. <strong>Table S9: </strong>Correlation between 26 modeling lncRNAs and 1572 potential drug targets. A correlation coefficient over 0.3 is considered exosome-related. <strong>Table S10: </strong> Trend tests for survival analysis in different significance test methods. <strong>Table S11: </strong> Correlation between 26 modeling lncRNAs and 1055 OS-related RBPs. A correlation coefficient over 0.2 is considered exosome-related.